학술논문
Trastuzumab deruxtecan in patients with HER2-positive advanced colorectal cancer (DESTINY-CRC02): primary results from a multicentre, randomised, phase 2 trial
Document Type
Article
Author
Raghav, Kanwal ; Siena, Salvatore ; Takashima, Atsuo; Kato, Takeshi; Van den Eynde, Marc; Pietrantonio, Filippo; Komatsu, Yoshito; Kawakami, Hisato; Peeters, Marc; Andre, Thierry; Lonardi, Sara; Yamaguchi, Kensei; Tie, Jeanne; Castro, Cristina Gravalos; Hsu, Hung-Chih; Strickler, John H; Kim, Tae-You; Cha, Yongjun; Barrios, Daniel; Yan, Qi; Kamio, Takahiro; Kobayashi, Kojiro; Boran, Aislyn; Koga, Makito; Allard, John D; Yoshino, Takayuki
Source
In The Lancet Oncology September 2024 25(9):1147-1162
Subject
Language
ISSN
1470-2045